Form 4: Entera Bio Director Haya Taitel Acquires and Disposes of Shares
SEC Form 4 Filing
Director Haya Taitel reports acquisition and disposal of Entera Bio shares on August 27, 2024.
Summary
- On August 27, 2024, Haya Taitel, a director of Entera Bio Ltd., engaged in transactions involving the company's ordinary shares.
- Taitel acquired 15,335 ordinary shares at a price of $0.
- Following these transactions, Taitel directly owns 50,450 ordinary shares.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider trading activity, which is a common occurrence for directors and officers of publicly traded companies.
Stakeholder Impact
- The transaction may have a minor impact on shareholder sentiment, depending on how the market interprets insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of the reported transaction (acquisition and disposal of shares). |
| 08/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.